The US E-Prescribing market is experiencing robust growth due to technological advancements, regulatory mandates, and increasing demand for streamlined healthcare solutions. Valued at USD 3,100 million in 2025, the market is projected to reach USD 8,950 million by 2035, growing at a CAGR of 10.9% between 2024 and 2035. Market players such as Cerner Corporation and Allscripts Healthcare Solutions are leveraging integrated software platforms and cloud-based solutions to meet the rising need for paperless prescriptions and interoperability across healthcare systems.
The economic impact of tariffs on "US E-Prescribing".
US E-Prescribing Market Growth Drivers
Government initiatives and regulatory mandates have accelerated the adoption of E-prescribing solutions in the US. The SUPPORT for Patients and Communities Act mandates the use of electronic prescribing for controlled substances under Medicare Part D, increasing the compliance pressure on healthcare providers. Companies like DrFirst are benefitting by offering solutions that specifically address these regulatory requirements, supporting health systems in seamless, compliant integrations.
The rising need for healthcare digitization and interoperability is fueling demand for E-prescribing systems. With the surge in telehealth, healthcare providers are seeking platforms that enable secure and efficient prescription management. Epic Systems Corporation and athenahealth, Inc. are expanding their cloud-based EHR platforms with advanced e-prescribing modules to ensure real-time data exchange, reducing medication errors and improving patient outcomes.
US E-Prescribing Market Trends
Integration of Artificial Intelligence (AI) and analytics is shaping the next generation of e-prescribing solutions. Companies like Surescripts are leveraging AI-powered medication history and decision support tools to enhance the prescribing process and reduce adverse drug events, enabling personalized and data-driven healthcare delivery.
Increasing adoption of mobile E-prescribing applications is a prominent trend. Providers such as Allscripts have introduced mobile apps that allow prescribers to send prescriptions directly to pharmacies on-the-go, benefitting both physicians and patients with convenience and improved access, particularly during remote care scenarios and public health emergencies.
US E-Prescribing Market Opportunities
There is a significant opportunity in expanding E-prescribing solutions into specialty medications and chronic disease management. Greenway Health is actively developing platforms that cater to complex e-prescribing workflows required by specialists, enabling better adherence and streamlined authorization processes.
Expansion into rural and underserved healthcare settings presents a growth area, as providers such as Practice Fusion are collaborating with community clinics to digitize prescription processes and improve medication access in remote areas.
US E-Prescribing Market Revenue (USD Million), 2020-2035
The US E-Prescribing market has demonstrated steady and substantial growth from 2020 to 2035. Beginning at USD 1,580 million in 2020, the market accelerated due to favorable regulations and healthcare digitization trends. By 2025, the market is estimated to reach USD 3,100 million. The revenue trajectory continues upward, propelled by enhanced telemedicine adoption and integrated EHR systems, culminating in a projected value of USD 8,950 million by 2035. This consistent CAGR of approximately 10.9% reflects increased stakeholder investments, technological advancements, and the shift towards value-based care and medication safety. The chart highlights a healthy, sustained ascent, indicating strong future prospects.
US E-Prescribing Market by Regions Share (%), 2025
The 2025 market share by region demonstrates the concentration of E-prescribing adoption in major US areas. The Northeast leads with 32%, reflecting strong presence of academic medical centers and urban healthcare systems. The Midwest follows at 27%, benefiting from robust health IT infrastructures. The South holds 20% share, driven by expanding healthcare delivery networks, while the West accounts for 16% due to tech-savvy states like California and Washington. Other regions (including territories) comprise 5%. The pie chart illustrates the dominance of established healthcare ecosystems on e-prescribing uptake while hinting at growth potentials in emerging markets.
US E-Prescribing Recent Developments (Last 6 Months)
In March 2024, Surescripts launched its Real-Time Prescription Benefit enhancement across leading EHR partners. This new feature enables prescribers to view patient-specific drug costs and therapeutic alternatives at the point of care, supporting informed decisions and affordability. Early pilots with Banner Health have demonstrated improved provider satisfaction and greater transparency in the prescribing workflow.
In April 2024, Allscripts Healthcare Solutions unveiled an advanced mobile e-prescribing application compatible with its Sunrise EHR platform. This release allows physicians to electronically prescribe controlled substances remotely, addressing compliance and security requirements. Collaborations with regional pharmacy chains aim to streamline medication access for patients across the South and West US regions.
In June 2024, DrFirst announced a partnership with CVS Health to integrate DrFirst’s AI-powered medication management into CVS’s digital pharmacy platform. The partnership aims to minimize prescription errors, improve adherence, and deliver actionable insights to both pharmacists and clinicians, enhancing patient safety and therapeutic outcomes.
Press Releases